Quantcast

Latest Genelux Corporation Stories

2013-07-19 23:01:51

Jamie Reno, an award-winning journalist, cancer survivor and patient advocate, discussed on his blog in depth recent discoveries by a small biotech firm in San Diego that has made significant advancement in cancer research. San Diego, CA (PRWEB) July 19, 2013 Jamie Reno, an award-winning journalist, cancer survivor and patient advocate, discussed in depth the discoveries by a small biotech firm in San Diego that has been flying under the radar for the past decade. What’s the big...

2011-08-04 14:16:00

SAN DIEGO, Aug. 4, 2011 /PRNewswire/ -- Genelux Corporation, a privately held, clinical stage biopharmaceutical company developing diagnostic and therapeutic solutions for cancer and inflammatory diseases, today announced the appointment of Dr. Catherine J. Mackey, long-time Pfizer executive, to the Company's Board of Directors. "In a career defined by excellence at every level, Dr. Mackey brings a unique set of skills and attributes that we believe will significantly complement and...

2011-01-24 11:00:00

SAN DIEGO, Jan. 24, 2011 /PRNewswire/ -- Genelux Corporation, a privately held, clinical stage biopharmaceutical company developing diagnostic and therapeutic solutions for cancer and inflammatory diseases, today announced the appointment of Dr. Dennis Fenton, long-time Amgen executive, to the company's Board of Directors. Dr. Fenton's appointment expands the Genelux Corporation board to 5 members. "As someone who helped to build one of the world's most successful pharmaceutical...

2011-01-12 06:00:00

SAN DIEGO, Jan. 12, 2011 /PRNewswire/ -- Genelux Corporation, a privately held, San Diego-based biopharmaceutical company developing novel therapies against cancer, today announced that its Board of Directors has appointed Jodi Devlin as the company's President effective January 10, 2011. Dr. Aladar Szalay, the company's Founder, will continue to serve as CEO and Chairman of the Board. "Ms. Devlin is an excellent choice to lead Genelux Corporation into the next phase of growth, from...

2007-11-12 21:00:07

SAN DIEGO, Nov. 12 /PRNewswire/ -- In its Oct. 15 issue, Cancer Research, published a peer-reviewed article from Genelux Corporation describing successful eradication of human breast cancer tumors in animals using GL-ONC1, a novel oncolytic virus developed by Genelux scientists. These promising results make a compelling case for the use of GL-ONC1 in human cancer patients. Clinical trials are scheduled to begin in the near future. "We believe this research represents a significant advance...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related